NEWS

WIRES

OTHER

Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects

    To view the Multimedia News Release, go to:
http://www.prnewswire.com/mnr/eqwestgroup/36121/

While developing new cancer therapies, the chief scientist, Dr. David Tsai, discovered that these peptides, once unlocked from their larger host protein, stimulate the production of the antioxidant enzyme Super Oxide Dismutase (SOD). When SOD was first discovered in 1968, it was dubbed 'the enzyme of life,' because it's the first antioxidant mobilized by the cell for defense. Cancer sufferers, especially those undergoing chemotherapy, often have high levels of free radicals, which deplete the body of antioxidants. As a result, vital organs can be overburdened and injured due to chemotherapy treatment. With AminoAct(TM), now available through OncoNutrition(TM), chemotherapy patients have access to a functional nutritional supplement that boosts their antioxidant levels and aids recovery from the damages of chemotherapy.

Cancer Treatment Review recently published a clinical review of 19 different studies indicating that antioxidant supplements taken by cancer patients resulted in increased survival time and increased treatment response. Antioxidants mainly come from two sources, either from nutrients like Vitamin C, or through antioxidant enzymes produced by the body. "AminoAct(TM) stimulates the body to produce its own antioxidants. Because our product works from the inside out, users benefit from a dramatic increase in their antioxidant levels," stated Olof Mollstedt, OncoNutrition's CEO.

"Our studies show that AminoAct(TM) increases the antioxidant levels in blood by over 200 percent in a seven-day period, while nutrient-based antioxidants only increase levels marginally." Mr. Mollstedt continued, "Antioxidants act as a shield for healthy cells, while allowing chemotherapy to battle cancerous cells. AminoAct(TM) greatly increases the size of that shield."

Because chemotherapy attacks not only cancer cells, but all cells, oftentimes cancer patients must stop treatment due to chemotherapy side effects. However, like antibiotics, chemotherapy is most effective when given in complete cycles. "By dramatically increasing antioxidant levels, AminoAct(TM) helps patients to stay on their chemotherapy regimens, thus increasing the overall treatment impact," stated Dr. Tsai.

In addition to stimulating SOD production, AminoAct(TM) also increases the secretion of ghrelin, a stomach hormone that stimulates appetite. According to the American Cancer Society, weight loss in the main cause of death for 1 in 5 cancer patients. "Our research was focused on eradicating cancer by allowing chemotherapy to do the job it's intended to do," Dr. Tsai said. "Knowing that cancer patients often succumb to death due to weight loss, when we uncovered that AminoAct(TM) also increases ghrelin production, we were elated."

The milk-based peptides in AminoAct(TM) are unlocked through a proprietary technology, and do not have adverse effects on those who are lactose intolerant. For more information, visit www.onconutrition.com, or call 951- 231-2388.

    Media Contacts:
    Chris French
    714-710-9229; 714-225-6142-C
    cfrench@eqwestgroup.com

    Helen Chen
    951-231-2106
    helenc@onconutrition.com

SOURCE OncoNutrition